Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in Kenya

Centers for Disease Control and Prevention770 enrolled

Overview

Randomised Controlled Trial to Assess Accuracy, Feasibility, Acceptability, Cost Effectiveness and Impact of Point of Care CD4 Testing on HIV Diagnosis, Linkage to Care and Time to Antiretroviral Therapy Initiation among HIV Infected Patients in Rural Western Kenya.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

770

Conditions

HIV

Interventions

Point of care CD4 device (Alere PIMA)DEVICE

for persons testing + with home-based HIV testing using Kenya's two rapid test algorithm, intervention arm participants received point of care CD4 testing followed by counseling on results which included their treatment eligibility

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: adults living in the study catchment area (Gem Village, Nyanza province Western Kenya) served by one of 23 HIV clinics and 3 referral labs * Not having received HIV care in prior 6 months if known HIV+ Exclusion Criteria: * current HIV care or HIV care within last six months

Locations (1)

CDC - KEMRI Field Research Station

Kisumu, Nyanza, Kenya

Outcomes

Primary Outcomes

Linkage to HIV care

As ascertained from clinic charts

Time frame: Within six months from date of study enrollment

ART initiation

As ascertained from clinic charts

Time frame: Within six months from date of study enrollment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.